Clinical and Molecular Characteristics of Post-Colonoscopy Colorectal Cancer: A Population-based Study

Gastroenterology

Volumn 151, Issue 5, 2016, Pages 870-878.e3

  Stoffel, Elena M ^a,b   Erichsen, Rune ^b   Frøslev, Trine ^b   Pedersen, Lars ^b   Vyberg, Mogens ^c   Koeppe, Erika ^a   Crockett, Seth D ^e   Hamilton, Stanley R ^d   Sørensen, Henrik T ^b   Baron, John A ^e  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c AALBORG UNIVERSITY HOSPITAL   (Denmark)

^d UNIVERSITY OF TEXAS   (United States)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Colon Cancer; Colorectal Neoplasm; Interval Cancer; Surveillance

Indexed keywords

MISMATCH REPAIR PROTEIN PMS2; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6;

AGED; ARTICLE; ASCENDING COLON; BRAF GENE; CANCER INCIDENCE; CLINICAL FEATURE; COLONOSCOPY; COLORECTAL CANCER; CROSS-SECTIONAL STUDY; DENMARK; DIAGNOSTIC PROCEDURE; FEMALE; GENE; GENE MUTATION; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; HUMAN TISSUE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MISMATCH REPAIR; POPULATION; PRIORITY JOURNAL; TUMOR LOCALIZATION; ADENOCARCINOMA; ADENOMA; ADULT; COLORECTAL NEOPLASMS; COMPARATIVE STUDY; DNA REPAIR-DEFICIENCY DISORDERS; GENETICS; INCIDENCE; MIDDLE AGED; PATHOLOGY; REGISTER; STATISTICAL MODEL; TIME FACTOR; VERY ELDERLY;

ADENOCARCINOMA; ADENOMA; ADULT; AGED; AGED, 80 AND OVER; COLONOSCOPY; COLORECTAL NEOPLASMS; CROSS-SECTIONAL STUDIES; DENMARK; DNA MISMATCH REPAIR; DNA REPAIR-DEFICIENCY DISORDERS; FEMALE; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; REGISTRIES; TIME FACTORS;

EID: 84994802233     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2016.07.010     Document Type: Article

References (43)

1. 1 Brenner, H., Haug, U., Arndt, V., et al. Low risk of colorectal cancer and advanced adenomas more than 10 years after negative colonoscopy. Gastroenterology 138 (2010), 870–876.
2. 2 Winawer, S.J., Zauber, A.G., Ho, M.N., et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 329 (1993), 1977–1981.
3. 3 Brenner, H., Chang-Claude, J., Seiler, C.M., et al. Protection from colorectal cancer after colonoscopy: a population-based, case-control study. Ann Intern Med 154 (2011), 22–30.
4. 4 Martinez, M.E., Baron, J.A., Lieberman, D.A., et al. A pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy. Gastroenterology 136 (2009), 832–841.
5. 5 Sawhney, M.S., Farrar, W.D., Gudiseva, S., et al. Microsatellite instability in interval colon cancers. Gastroenterology 131 (2006), 1700–1705.
6. 6 Kaminski, M.F., Regula, J., Kraszewska, E., et al. Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med 362 (2010), 1795–1803.
7. 7 Cooper, G.S., Xu, F., Barnholtz Sloan, J.S., et al. Prevalence and predictors of interval colorectal cancers in medicare beneficiaries. Cancer 118 (2012), 3044–3052.
8. 8 Singh, H., Nugent, Z., Demers, A.A., et al. Rate and predictors of early/missed colorectal cancers after colonoscopy in Manitoba: a population-based study. Am J Gastroenterol 105 (2010), 2588–2596.
9. 9 Corley, D.A., Jensen, C.D., Marks, A.R., et al. Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med 370 (2014), 1298–1306.
10. 10 Hosmer, D., Lemeshow, S., (eds.) Applied Logistic Regression, 2nd ed., 2000, Wiley and Sons, New York.
11. 11 Brenner, H., Chang-Claude, J., Jansen, L., et al. Role of colonoscopy and polyp characteristics in colorectal cancer after colonoscopic polyp detection: a population-based case-control study. Ann Intern Med 157 (2012), 225–232.
12. 12 Singh, S., Singh, P.P., Murad, M.H., et al. Prevalence, risk factors, and outcomes of interval colorectal cancers: a systematic review and meta-analysis. Am J Gastroenterol 109 (2014), 1375–1389.
13. 13 Samadder, N.J., Curtin, K., Tuohy, T.M., et al. Characteristics of missed or interval colorectal cancer and patient survival: a population-based study. Gastroenterology 146 (2014), 950–960.
14. 14 Nishihara, R., Wu, K., Lochhead, P., et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med 369 (2013), 1095–1105.
15. 15 Richter, J.M., Pino, M.S., Austin, T.R., et al. Genetic mechanisms in interval colon cancers. Dig Dis Sci 59 (2014), 2255–2263.
16. 16 Arain, M.A., Sawhney, M., Sheikh, S., et al. CIMP status of interval colon cancers: another piece to the puzzle. Am J Gastroenterol 105 (2010), 1189–1195.
17. 17 Shaukat, A., Arain, M., Thaygarajan, B., et al. Is BRAF mutation associated with interval colorectal cancers?. Dig Dis Sci 55 (2010), 2352–2356.
18. 18 Frank, L., Epidemiology. The epidemiologist's dream: Denmark. Science, 301(5630), 2003, 163.
19. 19 Lynge, E., Sandegaard, J.L., Rebolj, M., The Danish National Patient Register. Scand J Public Health 39:Suppl (2011), 30–33.
20. 20 Erichsen, R., Baron, J.A., Stoffel, E.M., et al. Characteristics and survival of interval and sporadic colorectal cancer patients: a nationwide population-based cohort study. Am J Gastroenterol 108 (2013), 1332–1340.
21. 21 Gjerstorff, M.L., The Danish Cancer Registry. Scan J Public Health 39:Suppl (2011), 42–45.
22. 22 Erichsen, R., Lash, T.L., Hamilton-Dutoit, S.J., et al. Existing data sources for clinical epidemiology: the Danish National Pathology Registry and Data Bank. Clin Epidemiol 2 (2010), 51–56.
23. 23 De Jesus-Monge, W.E., Gonzalez-Keelan, C., Zhao, R., et al. Mismatch repair protein expression and colorectal cancer in Hispanics from Puerto Rico. Fam Cancer 9 (2010), 155–166.
24. 24 Bartley, A.N., Luthra, R., Saraiya, D.S., et al. Identification of cancer patients with Lynch syndrome: clinically significant discordances and problems in tissue-based mismatch repair testing. Cancer Prev Res 5 (2012), 320–327.
25. 25 Greaves, W.O., Verma, S., Patel, K.P., et al. Frequency and spectrum of BRAF mutations in a retrospective, single-institution study of 1112 cases of melanoma. J Mol Diagn 15 (2013), 220–226.
26. 26 Portier, B.P., Kanagal-Shamanna, R., Luthra, R., et al. Quantitative assessment of mutant allele burden in solid tumors by semiconductor-based next-generation sequencing. Am J Clin Pathol 141 (2014), 559–572.
27. 27 Comprehensive molecular characterization of human colon and rectal cancer. Nature 487:7407 (2012), 330–337.
28. 28 Bellizzi, A.M., Frankel, W.L., Colorectal cancer due to deficiency in DNA mismatch repair function: a review. Adv Anat Pathol 16 (2009), 405–417.
29. 29 Djordjevic, B., Barkoh, B.A., Luthra, R., et al. Relationship between PTEN, DNA mismatch repair, and tumor histotype in endometrial carcinoma: retained positive expression of PTEN preferentially identifies sporadic non-endometrioid carcinomas. Mod Pathol 26 (2013), 1401–1412.
30. 30 Marrie, R.A., Dawson, N.V., Garland, A., Quantile regression and restricted cubic splines are useful for exploring relationships between continuous variables. J Clin Epidemiol 62 (2009), 511–517 e511.
31. 31 Rex, D.K., Ahnen, D.J., Baron, J.A., et al. Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol 107 (2012), 1315–1329 quiz 1314, 1330.
32. 32 Brenner, H., Chang-Claude, J., Seiler, C.M., et al. Interval cancers after negative colonoscopy: population-based case-control study. Gut 61 (2012), 1576–1582.
33. 33 Engel, C., Rahner, N., Schulmann, K., et al. Efficacy of annual colonoscopic surveillance in individuals with hereditary nonpolyposis colorectal cancer. Clin Gastroenterol Hepatol 8 (2010), 174–182.
34. 34 Jarvinen, H.J., Renkonen-Sinisalo, L., Aktan-Collan, K., et al. Ten years after mutation testing for Lynch syndrome: cancer incidence and outcome in mutation-positive and mutation-negative family members. J Clin Oncol 27 (2009), 4793–4797.
35. 35 Ladabaum, U., Ford, J.M., Martel, M., et al. American Gastroenterological Association technical review on the diagnosis and management of Lynch syndrome. Gastroenterology 149 (2015), 783–813 e720.
36. 36 Andersen, F.H., Ugeskr Laeger 169 (2007), 514–517.
37. 37 Rolighed, L.A.L.M., Ugeskr Laeger 170 (2008), 2232–2234.
38. 38 Dansk tarmkræftscreeningsdatabase Årsrapport 2014 Første 10 måneder 1. nationale screeningsrunde. Available at: https://www.sundhed.dk/content/cms/45/61245_dts%C3%A5rsrapport-2014_8-1-16_final_inklbilag.pdf2016. Accessed January 8, 2016.
39. 39 Bretthauer, M., Kaminski, M.F., Loberg, M., et al. Population-based colonoscopy screening for colorectal cancer: a randomized clinical trial. JAMA Intern Med 176 (2016), 894–902.
40. 40 Rex, D.K., Avoiding and defending malpractice suits for postcolonoscopy cancer: advice from an expert witness. Clin Gastroenterol Hepatol 11 (2013), 768–773.
41. 41 Baxter, N.N., Goldwasser, M.A., Paszat, L.F., et al. Association of colonoscopy and death from colorectal cancer. Ann Intern Med 150 (2009), 1–8.
42. 42 le Clercq, C.M., Bouwens, M.W., Rondagh, E.J., et al. Postcolonoscopy colorectal cancers are preventable: a population-based study. Gut 63 (2014), 957–963.
43. 43 Carethers, J.M., One colon lumen but two organs. Gastroenterology 141 (2011), 411–412.